- Posted: 20/12/18
Arrayjet is pleased to announce the sale of a Marathon Argus to a FTSE 100 company involved in pharmaceutical drug and vaccine development. Enclosed within the JetMosphere Max, the instrument is capable of printing microarrays at ultra low temperatures. The Iris Optical QC System consists of twin cameras that sit either side of the print head, capturing images and evaluating quality of the printed arrays in real-time.
A new microarray printer for the Department of Plant and Environmental Sciences at University of Copenhagen
- Posted: 22/03/18
The Section for Plant Glycobiology will be using their Marathon Argus to investigate plant cell wall polysaccharides, structure, synthesis, and degradation.
Arrayjet have a long-running relationship with the University of Copenhagen and are pleased to report this new installation.
Arrayjet are proud to welcome Dr. Joe Keegan, a globally renowned life science entrepreneur to join as non-executive director
- Posted: 03/08/17
We take great pride in announcing a game-changing addition of a new non-executive director, Dr Joseph Keegan to join our team. We are delighted to welcome Dr Joe Keegan, a San Francisco-based biotechnology entrepreneur and one of the most respected leaders in the life sciences industry, as our non-executive director to help drive forward future opportunities and make a transformative impact for the business.
Arrayjet business expansion translates into job creation and fuels next generation bio-printing technology
- Posted: 05/05/17
We are delighted to announce that our recent funding round led by Archangel Investors closed at £650,000. This will drive the expansion of Arrayjet Advance in-house consultancy services, increase our global commercial resources and bring new products to market. We have recently started the process of designing and developing its next generation bio-printing technological solutions with a new product scheduled for launch in 2018.